Commentary - (2015) Volume 4, Issue 3
The Role of Bevacizumab in the Management of Head and Neck Squamous Cell
Carcinoma Patients
- Yuh Baba1* and Yasumasa Kato2
- 1Department of General Clinical Medicine, Ohu University School of Dentistry, 31-1 Mitsumido, Tomiya-machi, Koriyama City, Fukushima 963-8611, Japan
- 2Department of Oral Function and Molecular Biology, Ohu University School of Dentistry, 31-1 Mitsumido, Tomiya-machi, Koriyama City, Fukushima 963-8611, Japan
*Corresponding Author:
Yuh Baba, Associate Professor of Department of General Clinical Medicine, Ohu University School of Dentistry, 31-1 Mitsumido, Tomiyamachi, Koriyama City, Fukushima 963-8611, Japan, Tel: +81-24-932-9360
Email:
